GT Biopharma (GTBP) Competitor Comparison
We are evaluating the key criteria listed to compare GT Biopharma (GTBP) against its competitors in the Biotechnology industry.
Market Capitalization
359 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
93 / 352Quick Ratio
257 / 357Earnings per Share
330 / 359Dividend yield
0 / 6Total Cash
307 / 358Performance 3 years
358 / 368Performance 5 years
328 / 368Performance 10 years
342 / 368Linearity 3 years
290 / 368Linearity 5 years
134 / 368Linearity 10 years
289 / 368Total Rank
139 / 368Dividend Rank
144 / 368Valuation Rank
368 / 368Piotroski Rank
123 / 368Muliplier Rank
4 / 368Linearity 3 years - GTBP ranking 290 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.